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PP-146 Establishment of highly efﬁcient full-length
HCV 1b genome cell culture system by inserting
long distant structural fragment into replicon
Y.L. Zeng1 *, Y.P. Zhou1, J.T. Li1, J.F. Wei1, H.H. Huang1,
J.J. Wang1, S.W. Liu2, Y.S. Wu2. 1Nanfang Hospital,
Southern Medical University, 2Southern Medical University,
China
Objectives: To establish a full-length genome of hepatitis C
virus (HCV) 1b, the dominant strain in China, cell culture
system for further study.
Methods: The 5′-end of half HCV-1b genome (5.2kb) was
ampliﬁed from Chinese chronic hepatitis C patients’ seral
samples with the reﬁned long distant RT-PCR technique. The
full length recombinant plasmid of HCV 1b was constructed
by inserting the long distant structural regions directly into
HCV 1b replicon containing the non-structural regions. In
vitro transcribed genomic HCVRNA was transfected into
Huh7.5.1 cells by liposome-mediated method. The real
time quantitative RT-PCR, Western Blot, inoculation of
naı¨ve Huh7.5.1 cells, immune ﬂuorescence and titration
of infectious HCV were used for identiﬁcation of HCV
replication and presence of infectious virion.
Results: The real time quantitative RT-PCR assay revealed
the highest titer of HCV was 6.5×107 copies/mL in the
cultural supernatants. While both Western Blot analysis and
immune ﬂuorescence conﬁrmed the expression of HCV core
protein in the transfected cells. Subsequent infection of
naı¨ve Huh7.5.1 cells with supernatant of HCV cell culture
resulted in high levels of HCV proteins and RNAs.
Conclusions: These results demonstrate the successful
establishment of a HCV 1b culture system by the new
strategy of inserting long distant structural amplicon into
replicon that produces infectious virus, which will allow the
study of each aspect of the entire HCV life cycle and related
studies.
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PP-147 Construction of a chimeric GB virus B with
hepatitis C virus NS2-NS4A
Z.X. Chen1, T.T. Li1, L.F. Shuai1, C.Y. Li1 *. 1School of
Biotechnology, Southern Medical University, China
Background: HCV infection became a worldwide threat
to human health, which can led to chronic hepatitis C,
cirrhosis and hepatoma. As only human and chimpanzees are
susceptible to hepatitis C virus, the progress of HCV research
has been obstructed due to the absence of a reliable small
primate animal model. GB virus B (GBV-B), being very close
to hepatitis C virus (HCV) phylogenetically, can replicate
effectively in vivio of common marmosets, that has been
made an attractive surrogate virus for HCV replication study.
It was reported that HCV NS2-NS3 protease, NS3 protease
and NS4A complex are critical for virus maturation and
replication. The construction of chimeric GB Virus B with
Hepatitis C NS2-NS4A region can be used to develop a
marmoset model for antiviral and immune studies.
Methods: RT-PCR and overlapping PCR were applied to
complete jointing gene fragments and T7 transcription kit
was used to produce chimeric GBV-B/HCV infectious RNA
in vitro.
Results: A chimeric clone originating from GB virus B
(GBV-B), in which GBV-B NS2-NS4A region are replaced by
analogous sequence of the HCV genome, was constructed.
Conclusions: This chimeric clone lays the roots for a
surrogate model of Hepatitis C virus, insights into HCV
replication mechanism and further HCV NS3 epitope-based
research.
PP-148 Comparisons of molecular responses between
recovery and chronic HCV infection from
blood donors in Beijing and Guangdong, China
T.T. Li1, Z.X. Chen1, J.F. Zeng2, L.F. Shuai1, J.G. Zhang3,
C.Y. Li1 *. 1School of Biotechnology, Southern Medical
University, 2Shenzhen Blood Center, 3Academy of Military
Medical Sciences, China
Background: Hepatitis C virus (HCV) infection is a major
public health problem in China. However systematic studies
conducted on mechanism of recovery and chronic infection
with HCV are little known. A detailed study was carried
out to investigate IFN-a and IFN-g correlating to antibody
reactivity and viral factors in the population of recovered
and chronic HCV infection from blood donors.
Methods: 160 plasmas samples reactive with anti-HCV
assays were collected from blood donors in Guangdong and
Beijing. HCV antibody reactivity was presented as S/CO by
at least three EIA assays. All samples were tested for ALT
and viral load, conﬁrmed by nested-PCR, and classiﬁed as
three statuses of recovery (RNA /Ab+), chronic (RNA+/Ab+)
and false positive (RNA /Ab ) infections. Productions of
IFN-a and IFN-g in the serum were also quantiﬁed
by ELISA. The genotypes of HCV from chronic samples
were phylogenetically analyzed with 5′-NCR sequences
(215 218bp).
Results: 45 recovery, 76 chronic and 39 false positive of 160
HCV antibody positive plasmas were ﬁnally conﬁrmed. The
rate of recovered HCV infected individuals in blood donors
was 37.2% proximately. 63 HCV strains were genotyped,
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including 42.9% genotype 1, 14.3% genotype 2, 19.0%
genotype 3 and 23.8% genotype 6. Genotype 1 was
predominant in Beijing, while genotype 6 was mainly
detected in Guangdong. The levels of IFN-g production
and antibody reactivity from chronic infection donors were
signiﬁcantly higher than those from recovery and false
positive infection donors (p < 0.001), but no statistical
difference of IFN-a among populations from three HCV
infection statuses was observed.
Conclusion: IFN-g but IFN-a may play a role paralleled with
antibody in viral clearance during natural history of HCV
infection.
PP-149 Seroprevalence of anti-HCV in children living in
Ulaanbaatar, Mongolia
D. Tungalag1 *, D. Davaasuren1, B. Baigal1, Y. Dahgwahdorj1.
1Health Science University of Mongolia, Mongolia
Background: Our previous study established that HCV
infection is wide-spread in Mongolia. So, many Government
and non-Government measures on HCV prevention are non-
speciﬁc. So, there is needed to check the results of the
measures.
Objective: To assess prevalence of HCV infection in
Mongolian children.
Methods: We randomly selected 199 “healthy” children
(ages 1 15) in May 2009, from Ulaanbaatar, matched by age
and sex and tested serum of all subjects for anti-HCV.
Results: Eighteen of 193 serum samples tested positive
for anti-HCV (9.3%). Older age was more likely to show a
positive test (presented in the table by age and sex).
Table 1. Anti HCV test results by age and number of subjects
Age Subjects Anti-HCV %
n male n male
1 21 12 0 0
3 24 14 0 0
5 28 14 3 2 10.7
7 26 12 0 0
9 26 13 4 3 15.4
11 23 12 3 2 13.0
13 23 10 3 1 13.0
15 22 12 5 2 22.7
Total 193 99 18 10 9.3
Discussion and Conclusion: More half the population of
Mongolia lives in Ulaanbaatar. We have carried two
studies on the prevalence of HCV infection in children in
Ulaanbaatar (1998, 2002). These studies did not showed
a signiﬁcant difference in HCV seroprevalcne between
rural and urban subjects. As the results, we estimate the
prevalence of HCV infection in Ulaanbaatar to the ﬁgure
for the whole Mongolian population. The seroprevalence,
found in this study is signiﬁcantly higher compared with our
previous study. Therefore, all measures to help prevent HCV
infection in Mongolia should be intensiﬁed.
PP-150 Evaluation of serum TIMP-1 & TGF-b1 in
Egyptian patients with chronic hepatitis C,
genotype 4 & chronic hepatitis B infection
H. El Garem1 *, G. El deen Esmat1, O. Shaker1,
M. Mohaned1, A. Salama1, A. Abolfotoh1. 1Cairo University,
Egypt
Background: HCV & HBV infections are known to be
major public health problem in Egypt. As chronic liver
disease progresses, an imbalance occurs between synthesis
and breakdown of extra cellular matrix (ECM). Matrix
metallproteinases (MMPs) are involved in degrading ECM
while tissue inhibitors of metalloproteinases (TIMPs) prevent
their ﬁbrolytic action. Transforming growth factor b1
(TGF-b1) is a key mediator of liver ﬁbrogenesis. Aim of this
study is evaluating TIMPs & TGF-b1 as ﬁbrogenic seromarkers
in comparison to histopathological examination of liver.
Methods: Commercially available ELISA assays were used
to study circulating levels of TIMP-1 & TGF-b1 in 50
patients with chronic hepatitis C patients and 20 patients
with chronic hepatitis B compared to 10 healthy control
subjects.
Results: In HCV patients, TIMP-1 was elevated with more
progresive liver disease with a sensitivity of 100% the
speciﬁcity of 87%. Serum level of TIMP-1 in chronic
hepatitis (B) was slightly decreased from healthy control
without signiﬁcant correlation. Its mean and standard
deviation was (157.81±44.1) and (164.18±42.22) in the
HBV and control group respectively.
In comparison between HCV & HBV patients there was
signiﬁcant increase in serum level of TIMP-1 in HCV patients
than HBV patients.
Serum levels of TGF-b1 were decreased in HCV patients
signiﬁcantly from healthy control group (mean 138.27±47.8)
to F4 patients (mean 46.97±23.49). Serum levels of
TGF-b1 in chronic hepatitis B patients showed no statistical
difference from the healthy control. Its mean and standard
deviation in HBV group and control group were (114.9±53.11
and 138.37±47.86) respectively.
Conclusion: TIMP-1 is a reliable predictor to detect
advanced ﬁbrosis, in HCV patients genotype 4.
PP-151 Increased PD-L1 expression and PD-L1/CD86
ratio on dendritic cells were inversely
associated with impaired dendritic cells
function in HCV chronic infection
T. Shen1 *, X.M. Chen1, Q. Xu1, S. Liu2, F.M. Lu1.
1Department of Microbiology, Peking University Health
Science Center, Beijing 100191, China, 2Artiﬁcial Liver
Center, Beijing You’an Hospital, Afﬁliated to Capital
Medical University, Beijing 100069, China
Hepatitis C virus (HCV)-speciﬁc T cell immunity was impaired
in HCV chronic infection and resulted in the persistence
of HCV infection. Dysfunction of dendritic cells (DCs) was
believed to be involved in this T cell exhaustion, but the
mechanisms were rarely understood.
In this study, we evaluated surface costimulatory marker
(CD83, CD86, and CD40) and coinhibitory marker (PD-L1)
expression and allostimulatory capacity of plasmacytoid
DCs and myeloid DCs in twenty ﬁve HCV-infected patients
compared to twenty healthy controls. All patients and
control were seronegative for anti-HIV and anti-HBV. DCs
were isolated from PBMC by use of BDCA-1 positive
cell isolation kit for myeloid DCs and BDCA-4 positive
cell isolation kit for plasmacytoid DCs according to the
manufacturer’s instructions.
We found both costimulatory marker and coinhibitory
marker expression were increased in HCV infection
compared with healthy control. The ratio of PD-L1 versus
CD86 was also increased in HCV-infected patients and
the ratio positive correlated with PD-L1 expression on
DCs. Allostimulatory capacity of DCs was impaired in HCV
infection and this allogeneic MLR was inversely correlated
with PD-L1 expression and PD-L1/CD86 ratio.
These ﬁndings suggested that the effect of inhibitory marker
PD-L1 overwhelmed the effect of costimulatory markers
and negatively regulated DC-T activation. Our ﬁnding will
be helpful to understand the mechanism of dysfunction
